Cover Image
Market Research Report

United States Prosthetic Heart Valves Market Outlook to 2025

Published by GlobalData Product code 302397
Published Content info 64 Pages
Delivery time: 1-2 business days
Price
Back to Top
United States Prosthetic Heart Valves Market Outlook to 2025
Published: April 2, 2018 Content info: 64 Pages
Description

GlobalData's new report, "United States Prosthetic Heart Valves Market Outlook to 2025", provides key market data on the United States Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Tissue Heart Valves, Transcatheter Heart Valves and Mechanical Heart Valves.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Prosthetic Heart Valves market segments - Tissue Heart Valves, Transcatheter Heart Valves and Mechanical Heart Valves.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Prosthetic Heart Valves market.
  • Global corporate-level profiles of key companies operating within the United States Prosthetic Heart Valves market.
  • Key players covered include Abbott Laboratories, Medtronic plc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
Product Code: GDMECC2979DB

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 What Is This Report About? 5
  • 2.2 Prosthetic Heart Valves Market Segmentation 5
  • 2.3 Definitions of Markets Covered in the Report 6

3 Prosthetic Heart Valves Market, United States 8

  • 3.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2015-2025 8
    • 3.1.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 11
    • 3.1.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 13
    • 3.1.3 Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025 15
  • 3.2 Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025 17
    • 3.2.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 19
    • 3.2.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 21
    • 3.2.3 Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025 23
  • 3.3 Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2025 25
  • 3.4 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2017 27
  • 3.5 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2017 28

4 Overview of Key Companies in United States, Prosthetic Heart Valves Market 30

  • 4.1 Edwards Lifesciences Corp 30
    • 4.1.1 Company Overview 30
  • 4.2 Medtronic Plc 30
    • 4.2.1 Company Overview 30
  • 4.3 Abbott Laboratories 30
    • 4.3.1 Company Overview 30

5 Prosthetic Heart Valves Market Pipeline Products 31

6 Financial Deals Landscape 32

  • 6.1 Acquisition 32
    • 6.1.1 LivaNova Acquires Remaining 51% Stake in Caisson Interventional 32
  • 6.2 Venture Financing 33
    • 6.2.1 Hancock Jaffe Lab Raises USD1 million in Venture Financing 33

7 Recent Developments 34

  • 7.1 Corporate Communications 34
    • 7.1.1 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 34
    • 7.1.2 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 34
    • 7.1.3 Jun 15, 2017: FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus 35
    • 7.1.4 May 18, 2017: Edwards Lifesciences' Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020 35
  • 7.2 Financial Announcements 36
    • 7.2.1 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 36
    • 7.2.2 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 37
    • 7.2.3 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 38
    • 7.2.4 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 40
    • 7.2.5 Oct 26, 2017: Bicycle Therapeutics to Present Preclinical Data on Lead Molecule BT1718 at the AACR-NCI-EORTC International Cancer Conference 41
    • 7.2.6 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 43
    • 7.2.7 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference 44
    • 7.2.8 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine 44
    • 7.2.9 Aug 15, 2017: CareRay Exhibits At FIME 2017 47
    • 7.2.10 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 48
    • 7.2.11 Jul 13, 2017: CareDx provides 100,000th AlloMap to heart transplant patients 49
    • 7.2.12 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 49
  • 7.3 Government and Public Interest 51
    • 7.3.1 Dec 15, 2017: Oxford Immunotec and QIAGEN Resolve Patent Infringement Lawsuit involving QuantiFERON-TB Gold Plus 51
  • 7.4 Legal And Regulatory 51
    • 7.4.1 Nov 03, 2017: Neovasc Provides Litigation Update 51
  • 7.5 Product News 52
    • 7.5.1 Nov 08, 2017: Mechanical heart valve often the safest choice 52
    • 7.5.2 Oct 04, 2017: Study shows low mortality, stroke risks for minimally invasive aortic valve replacements 53
    • 7.5.3 May 18, 2017: Wyss Institute: Engineering heart valves for the many 54
  • 7.6 Strategy And Business Planning 55
    • 7.6.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 55
    • 7.6.2 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients 56

8 Appendix 58

  • 8.1 Research Methodology 59
    • 8.1.1 Coverage 59
    • 8.1.2 Secondary Research 59
    • 8.1.3 Primary Research 60
    • 8.1.4 Market Modeling and Forecasting 61
    • 8.1.5 Company Share Analysis 62
    • 8.1.6 Distribution Share Analysis 63
    • 8.1.7 Benchmarking 63
  • 8.2 GlobalData Consulting 63
  • 8.3 Contact Us 64
  • 8.4 Disclaimer 64

List of Tables

1.1 List of Tables

  • Table 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 9
  • Table 2: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 10
  • Table 3: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 12
  • Table 4: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 12
  • Table 5: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 14
  • Table 6: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 14
  • Table 7: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020 16
  • Table 8: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025 16
  • Table 9: Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2020 18
  • Table 10: Prosthetic Heart Valves Market, United States, Volume (Units), 2021-2025 18
  • Table 11: Mechanical Heart Valves Market, United States, Volume (Units), 2015-2020 20
  • Table 12: Mechanical Heart Valves Market, United States, Volume (Units), 2021-2025 20
  • Table 13: Tissue Heart Valves Market, United States, Volume (Units), 2015-2020 22
  • Table 14: Tissue Heart Valves Market, United States, Volume (Units), 2021-2025 22
  • Table 15: Transcatheter Heart Valves Market, United States, Volume (Units), 2015-2020 24
  • Table 16: Transcatheter Heart Valves Market, United States, Volume (Units), 2021-2025 24
  • Table 17: Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2020 25
  • Table 18: Prosthetic Heart Valves Market, United States, Average Price ($), 2021-2025 26
  • Table 19: Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 27
  • Table 20: Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2017 29
  • Table 21: Prosthetic Heart Valves Market Pipeline Products 31
  • Table 22: LivaNova Acquires Remaining 51% Stake in Caisson Interventional 32
  • Table 23: Hancock Jaffe Lab Raises USD1 million in Venture Financing 33
  • Table 24: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 61

List of Figures

1.2 List of Figures

  • Figure 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 8
  • Figure 2: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 11
  • Figure 3: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 13
  • Figure 4: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025 15
  • Figure 5: Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025 17
  • Figure 6: Mechanical Heart Valves Market, United States, Volume (Units), 2015-2025 19
  • Figure 7: Tissue Heart Valves Market, United States, Volume (Units), 2015-2025 21
  • Figure 8: Transcatheter Heart Valves Market, United States, Volume (Units), 2015-2025 23
  • Figure 9: Prosthetic Heart Valves Market, United States, Company Share (%) 2017 28
Back to Top